ESC 365 - Angioplasty of flow limiting stenosis improves left ventricular diastolic dysfunction in patients with peripheral artery disease

ESC Premium Access

Angioplasty of flow limiting stenosis improves left ventricular diastolic dysfunction in patients with peripheral artery disease

Session: Peripheral Vascular and Cerebrovascular Disease ePosters

Topic: Peripheral Artery Disease

Speaker: Mr S. Baasen (Duesseldorf, DE)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Mr Sven Baasen

University Hospital Duesseldorf, Duesseldorf (Germany)

0 follower

18 more presentations in this session

Impact of polyvascular disease on the prognosis of acute coronary syndrome

Speaker: Professor N. Laraba (Algiers, DZ)

The efficacy and safety of dual-pathway inhibition therapy among patients with peripheral arterial disease - a meta-analysis

Speaker: Doctor J. Mapili (Manila, PH)

Total thrombus-formation analysis system (T-TAS) can predict target lesion revascularization in patients undergoing endovascular therapy for critical limb ischemia

Speaker: Doctor N. Kuyama (Osaka, JP)

Temporal course of vascular response after fluoropolymer paclitaxel-eluting stent implantation for femoropopliteal artery lesions

Speaker: Doctor Y. Tomoi (Fukuoka, JP)

Pre-dilatation prior to carotid artery stenting in very severe carotid artery stenosis: beneficial or detrimental?

Speaker: Doctor M. Keskin (Istanbul, TR)

Access the full session

Peripheral Vascular and Cerebrovascular Disease ePosters

Speakers: Mr S. Baasen, Professor N. Laraba, Doctor J. Mapili, Doctor N. Kuyama, Doctor Y. Tomoi...

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

Renal decline in patients with atrial fibrillation treated with rivaroxaban or warfarin: a population-based cohort study in the United Kingdom

27 August 2021

ESC Premium Access

The HEP-COVID Trial

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

ESC 365 is supported by